U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07852247) titled 'SBRT for Ultra-Central NonSmall Cell Lung Cancer' on Sept. 23.
Brief Summary: The goal of this clinical trial is to find out if Five-fraction CyberKnife stereotactic body radiation therapy (SBRT) with real-time Synchrony(R) motion tracking can treat ultra-central nonsmall cell lung cancer while reducing the amount of serious side effects from SBRT. Participants will
* receive radiation treatment every other day over two weeks using a machine called the CyberKnife(R), which uses a technology called Synchrony(R) motion management, which tracks your tumor in real time as it moves with your breathing. This allows the radiation beam to f...